Belinda Juran is a partner in the Technology Transactions and Licensing Practice Group and the Life Sciences Group. She joined the firm in 1998.
Practice
Ms. Juran's practice focuses on advising clients on technology-centered transactions. She helps biotechnology, pharmaceutical, medical device, high technology, green technology and service companies achieve their strategic goals by advising them on all phases of their product development and commercialization relationships. Ms. Juran negotiates and advises clients on collaboration, development, distribution, license and service agreements with customers, suppliers, licensors, licensees and other third parties, and on the acquisition and sale of intellectual property and joint venture arrangements. She works with clients on matters ranging from bet-the-company billion-dollar global strategic collaborations to day-to-day issues. Ms. Juran also has provided general corporate advice to public and private companies and represented companies in venture capital financings, initial public offerings and mergers and acquisitions.
Ms. Juran provides her clients with practical insights by combining her experience and education in technology, business and law. Prior to practicing law, Ms. Juran worked in the high technology industry for several years, where she developed sophisticated computer-aided engineering software, then managed engineering departments. She has also been a consultant to several high technology companies.
Recent Highlights
- Represented Infinity Pharmaceuticals in a broad drug discovery collaboration with Purdue
- Represented Synta Pharmaceuticals in a development and commercialization collaboration with Hoffman-La Roche for drugs to treat inflammatory diseases
- Represented Regulus Therapeutics in a collaboration with GSK to develop and commercialize microRNA therapeutics for inflammatory diseases
- Advised Broadcom on the acquisition of the digital television business from Advanced Micro Devices
Presentations
- Pacific Rim Advisory Council: “From Conception to Litigation: Patent Law Issues in the United States, Japan and China” - April 2009
- BIO (Biotechnology Industry Organization) General Counsels’ Committee Meeting: “Dispute Resolution” - October 2008
- BIO (Biotechnology Industry Organization) International Convention: “What Every Licensing Professional Should Know About University Licensing and Spin-Outs” – June 2008
- LES (Licensing Executives Society) Annual Meeting: “Maximizing Value in License Agreements”– October 2005
Publications
- Ms. Juran was quoted in the January 15, 2010 article "Experts Predict Top Life Sciences Issues in 2010," which appeared in the Bureau of National Affairs' Life Sciences Law & Industry Report.
- Juran, Belinda, Stuart Falber, Andrew Gilbert, and Stuart R. Nayman. "Preparing To Go Public: Practical Insights for Biotech Companies." The Journal of Biolaw & Business 4, no. 4 (2004).
- Juran, Belinda, David Cerveny, and John Butts. "US Supreme Court Foreshadows the Constitutional Analysis of Database Protections." Hale and Dorr LLP E-Alert (December 19, 2003).
- Juran, Belinda, and Irah Donner. "Who Invented Hyperlinks? Summary Judgment for the Defendant in the BT Case." Hale and Dorr LLP E-Alert (September 5, 2002).
- Juran, Belinda, and Irah Donner. "Who Invented Hyperlinks? IP Audit Uncovers Potentially Valuable Patent." Hale and Dorr LLP E-Alert (April 17, 2002).
- Juran, Belinda, and Mark Matuschak. "A Second Bite at the Apple: Domain Name Registrants Can Use Anticybersquatting Statute to Reverse UDRP Proceeding." Hale and Dorr LLP E-Alert (February 13, 2002).
- Juran, Belinda, Alfred Server, and Jan Siok. "Bioinformatics – New Legal Issues Raised in the Intersection of Computer Science, Biology and the Internet." Hale and Dorr LLP E-Alert (November 5, 2001).
- Juran, Belinda, Michael Diener, and contributions from Benjamin Koch. "Trade Secret Protection for Source Code." Hale and Dorr LLP E-Alert (July 17, 2001).
Professional Activities
Ms. Juran has participated in the M. Ellen Carpenter Financial Literacy Program conducted through the Boston Bar Association.
Honors and Awards
